These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 9512103)
41. Relationship between occupational risk factors and severity markers of systemic sclerosis. Magnant J; de Monte M; Guilmot JL; Lasfargues G; Diot P; Asquier E; Degenne D; Boissinot E; Diot E J Rheumatol; 2005 Sep; 32(9):1713-8. PubMed ID: 16142866 [TBL] [Abstract][Full Text] [Related]
42. The incidence, prevalence, and survival of systemic sclerosis in the UK Clinical Practice Research Datalink. Royle JG; Lanyon PC; Grainge MJ; Abhishek A; Pearce FA Clin Rheumatol; 2018 Aug; 37(8):2103-2111. PubMed ID: 29961234 [TBL] [Abstract][Full Text] [Related]
43. Keloid morphea and nodular scleroderma: two distinct clinical variants of scleroderma? Rencic A; Brinster N; Nousari CH J Cutan Med Surg; 2003; 7(1):20-4. PubMed ID: 12362259 [TBL] [Abstract][Full Text] [Related]
45. [Scleroderma in a hospital setting in Togo]. Pitche P; Amanga Y; Koumouvi K; Oniankitan O; Mijiyawa M; Tchangaï-Walla K Med Trop (Mars); 1998; 58(1):65-8. PubMed ID: 9718559 [TBL] [Abstract][Full Text] [Related]
46. Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases. Marzano AV; Menni S; Parodi A; Borghi A; Fuligni A; Fabbri P; Caputo R Eur J Dermatol; 2003; 13(2):171-6. PubMed ID: 12695134 [TBL] [Abstract][Full Text] [Related]
47. Systemic sclerosis sine scleroderma: distinct features in a large Brazilian cohort. Marangoni RG; Rocha LF; Del Rio AP; Yoshinari NH; Marques-Neto JF; Sampaio-Barros PD Rheumatology (Oxford); 2013 Aug; 52(8):1520-4. PubMed ID: 23661427 [TBL] [Abstract][Full Text] [Related]
48. Epidemiology of systemic sclerosis in northwest Greece 1981 to 2002. Alamanos Y; Tsifetaki N; Voulgari PV; Siozos C; Tsamandouraki K; Alexiou GA; Drosos AA Semin Arthritis Rheum; 2005 Apr; 34(5):714-20. PubMed ID: 15846586 [TBL] [Abstract][Full Text] [Related]
49. Palindromic morphea: multiple recurrence of morphea lesions in a case of systemic sclerosis. Mizutani H; Tanaka H; Okada H; Mizutani T; Shimizu M J Dermatol; 1992 May; 19(5):298-301. PubMed ID: 1644954 [TBL] [Abstract][Full Text] [Related]
50. [Age-sex aspects of distribution of children with scleroderma according to clinical forms]. Popik GS Pediatriia; 1990; (12):81-2. PubMed ID: 2075074 [No Abstract] [Full Text] [Related]
51. Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects. Diab S; Dostrovsky N; Hudson M; Tatibouet S; Fritzler MJ; Baron M; Khalidi N; J Rheumatol; 2014 Nov; 41(11):2179-85. PubMed ID: 25274885 [TBL] [Abstract][Full Text] [Related]
52. [Scleroderma and thyroid diseases]. Mourier-Clavreul MC; Rousset H; Claudy A Ann Dermatol Venereol; 1989; 116(10):701-6. PubMed ID: 2692498 [TBL] [Abstract][Full Text] [Related]
53. Pediatric scleroderma. Emery H Semin Cutan Med Surg; 1998 Mar; 17(1):41-7. PubMed ID: 9512106 [TBL] [Abstract][Full Text] [Related]
54. Predictive value of European Scleroderma Group Activity Index in an early scleroderma cohort. Nevskaya T; Baron M; Pope JE; Rheumatology (Oxford); 2017 Jul; 56(7):1111-1122. PubMed ID: 28340090 [TBL] [Abstract][Full Text] [Related]
55. Frequency, levels, and significance of blood eosinophilia in systemic sclerosis, localized scleroderma, and eosinophilic fasciitis. Falanga V; Medsger TA J Am Acad Dermatol; 1987 Oct; 17(4):648-56. PubMed ID: 3668010 [TBL] [Abstract][Full Text] [Related]
56. Clinical characteristics associated with antihistone antibodies in patients with localized scleroderma. Sato S; Fujimoto M; Ihn H; Kikuchi K; Takehara K J Am Acad Dermatol; 1994 Oct; 31(4):567-71. PubMed ID: 8089281 [TBL] [Abstract][Full Text] [Related]
58. [Classification of circumscribed scleroderma. A multicenter study of 286 patients. The Scleroderma Study Group of the Society of Dermatologic Research]. Hautarzt; 1990 Jan; 41(1):16-21. PubMed ID: 2179167 [TBL] [Abstract][Full Text] [Related]
59. Scleroderma: nomenclature, etiology, pathogenesis, prognosis, and treatments: facts and controversies. Fett N Clin Dermatol; 2013; 31(4):432-437. PubMed ID: 23806160 [TBL] [Abstract][Full Text] [Related]